35 results
Page 2 of 2
8-K
EX-10.1
w5btl
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-10.1
j4uv s3rw91
10 Jul 15
EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437 Combination Product in Uveitis
12:00am
10-K
257n4 ww7bbx0uxe466z
31 Mar 15
Annual report
12:00am
424B4
7jqgve5q1rn5xx24e9
13 Feb 15
Prospectus supplement with pricing info
12:00am
DRS/A
f8sck8llqoz2uxqdn
8 Jul 14
Draft registration statement (amended)
12:00am